VSee Health, Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending March 31, 2025. The company generated total revenues of $3.32 million, a substantial increase of 105% compared to $1.62 million in the same period last year. This growth was primarily driven by the acquisition of iDoc, which contributed approximately $1.20 million in patient and telehealth fees. However, the company also faced increased costs, with cost of revenues rising to $1.46 million from $386,253, leading to a gross margin of $1.86 million, up from $1.23 million.
Despite the revenue growth, VSee Health reported a net loss of $3.96 million for the quarter, a significant increase from a net income of $94,750 in the prior year. The loss was attributed to higher operating expenses, which surged to $3.69 million from $1.13 million, largely due to increased compensation and general administrative costs following the iDoc acquisition. The company also incurred substantial interest expenses, totaling $730,665, reflecting its ongoing financing activities.
Operationally, VSee Health has made strides in expanding its customer base and service offerings. The company reported a total of 17,022,690 shares of common stock outstanding as of October 14, 2025, and has been actively engaging in new contracts with larger hospitals. The company’s telehealth platform continues to gain traction, with increased utilization of physician services contributing to revenue growth. However, the company also noted a decline in recurring subscription revenues, which it aims to address through strategic initiatives.
Looking ahead, VSee Health's management expressed optimism about future growth, citing a robust pipeline of contracts and ongoing negotiations for additional financing to support its working capital needs. The company is focused on enhancing its telehealth offerings and expanding its market presence, particularly in the wake of the ongoing transformation in the healthcare sector. However, management acknowledged the challenges posed by its current financial position and the need for effective execution of its growth strategies to ensure long-term sustainability.
About VSEE HEALTH, INC.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.